WK
Walter Klemp V bought MBRX stock
Walter Klemp V, CEO and President of Moleculin Biotech, Inc. (MBRX), bought 533,333 shares of MBRX stock, per an SEC Form 4 filed Aug 5, 2026.
The shares came through a private deal, not the open market.
The trade happened on Aug 3, 2026, 2 days before it was made public.
MBRX has moved -8.9% since the trade date, from $8.50 to $7.74 (Nov 20, 2026 close).
- Traded
- Aug 3, 2026
- Disclosed
- Aug 5, 2026
- Filing delay
- 2 days
- Price since
- -8.9%
- Role
- CEO and President
- Source
- SEC Form 4